Abiopharma

🔍 Tierney David S (Director)

Company: CATALYST PHARMACEUTICALS, INC. (CPRX)

Report Date: 2025-08-27

Detailed Transactions and Holdings:

• Acquired 50,000 shares of Common Stock, par value $0.001 per share at $2.24 per share (Direct)
  Date: 2025-08-27 | Code: M | equity_swap_involved: 0 | shares_owned_after: 405,620.00 | transaction_form_type: 4
• Sold 26,000 shares of Common Stock, par value $0.001 per share at $20.2 per share (Direct)
  Date: 2025-08-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 379,620.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 50,000 shares of Options to purchase common stock at $2.24 per share (Derivative)
  Date: 2025-08-27 | Code: M | Expires: 2025-12-19 | equity_swap_involved: 0 | shares_owned_after: 158,274.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Shares were sold on the open market to fund the exercise price and estimated taxes due from Reporting Person as a result of the exercise of the stock options reported on Table II.
• F2: Represents a weighted average sales price for the shares sold. Shares were sold in a range from $20.10 to $20.32 per share.
• F3: Derivative securities vested in three annual tranches beginning on December 19, 2019.